Log In
Print
BCIQ
Print
Print this Print this
 

Anti-Notch2/3, tarextumab (OMP-59R5)

  Manage Alerts
Collapse Summary General Information
Company OncoMed Pharmaceuticals Inc.
DescriptionHuman HuCAL mAb that binds selected Notch receptors
Molecular Target Notch 2 (NOTCH2) ; Notch 3 (NOTCH3)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today